Fusion Family Wealth LLC Abb Vie Inc. Transaction History

Fusion Family Wealth LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$105.21 - $117.21 $10,836 - $12,072	-103 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $16,902 - $22,820	-210 Reduced 67.09%	103 $11,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $7,474 - $8,772	87 Added 38.5%	313 $27,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $9,024 - $12,076	123 Added 119.42%	226 $22,000
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $6,738 - $8,102	-107 Reduced 50.95%	103 $8,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $7,029 - $8,985	107 Added 103.88%	210 $15,000
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $8,253 - $9,714	-107 Reduced 50.95%	103 $8,000
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $3,467 - $3,854	-39 Reduced 15.66%	210 $20,000
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $9,247 - $10,941	103 Added 70.55%	249 $23,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $13,075 - $14,338	146 New	146 $14,000
Q3 2017 Oct 30, 2017	SELL	$69.85 - $89.22 $10,198 - $13,026	-146 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	146	146 $11,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fusion Family Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Fusion Family Wealth LLC with notifications on news.